2022 Revenue Increased to $440.5 Million , Versus $318.7 Million in 2021, an Increase of 38% Full Year Revenue up 75% Year-Over-Year Excluding Mass Covid Testing Company introduces Full-Year 2023 Revenue and Adjusted EBITDA 1 Guidance of $500-$510 million and $45-$50 million , respectively Company
NEW YORK --(BUSINESS WIRE)--Feb. 27, 2023-- DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone , Chief Executive Officer will present at the upcoming Cowen 43rd Annual in Boston on Tuesday, March 7 at 2:10PM Eastern Time .
Management to host investor conference call and webcast at 5:00pm ET on that day NEW YORK --(BUSINESS WIRE)--Feb. 21, 2023-- DocGo , a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the fourth quarter and full-year ended
NEW YORK --(BUSINESS WIRE)--Jan. 12, 2023-- DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced a partnership with Redirect Health , a platform that creates and manages healthcare solutions for businesses and employees nationwide, to provide on-demand,
NEW YORK --(BUSINESS WIRE)--Jan. 3, 2023-- DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone , Chief Executive Officer will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 12 at
